To this end, due to the pronounced effects of bestatin as an anti-cancer drug [22,23] and the availability of the LTA4H-bestatin complex crystal structure, we used bestatin binding interactions with LTA4H, inferred from the crystal structure, to search for LTA4H inhibitors with novel chemotypes as potential anti-cancer agents. This evidence concerns the gene LTA4H and cancer.